ArticleLaryngoscope investigative otolaryngology2026
Radiologic Sarcopenia and Charlson Comorbidity Index in the Head and Neck Free Flap Population.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Determining operative risk in patients undergoing head and neck free flap surgery has traditionally been difficult. Psoas muscle mass, a proven frailty marker in abdominal surgery, has not been evaluated in this population. This study demonstrates that radiologic sarcopenia and comorbidity burden may identify patients at higher risk for non-home discharge. Methods: A retrospective review was performed on 308 patients who underwent head and neck free flap surgery and had preoperative abdominal CT scans between 2014 and 2024. Inverse Psoas Muscle Index (PMI) and Charlson Comorbidity Index (CCI) were analyzed to assess the impact of radiologic sarcopenia and comorbidity on discharge disposition. Results: Higher inverse PMI had increased odds of discharge non-home (OR 1.37, 95% CI 1.05-1.77, Conclusion: Lower psoas muscle mass, reflected by higher inverse PMI, independently predicts non-home discharge, supporting its role as a frailty marker in head and neck free flap patients. Patients with higher comorbidity burden, as measured by CCI, have higher odds of non-home discharge. Combining radiologic muscle assessment (inverse PMI) with comorbidity indices demonstrates strong predictive potential for non-home discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.